Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.

Persons of blood group O are at increased risk of developing cholera gravis. In a randomized, placebo-controlled, double-blind safety-immunogenicity trial of live oral cholera vaccine CVD 103-HgR in 5- to 9-year-old Chilean children, vibriocidal antibody seroconversion (74% overall) did not differ b...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Infect Immun
Asıl Yazarlar:	Lagos, R, Avendaño, A, Prado, V, Horwitz, I, Wasserman, S, Losonsky, G, Cryz, S, Kaper, J B, Levine, M M
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1995
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC173056/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7822046/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.63.2.707-709.1995
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.

Benzer Materyaller